HomeLBRX • NASDAQ
add
LB Pharmaceuticals Inc
Previous close
$15.62
Day range
$15.48 - $16.57
Year range
$13.40 - $20.25
Avg Volume
299.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.29M | -80.08% |
Net income | -5.09M | 81.63% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.22M | 80.37% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.22M | -80.28% |
Total assets | 19.25M | — |
Total liabilities | 8.86M | — |
Total equity | 10.39M | — |
Shares outstanding | 251.79K | — |
Price to book | -0.04 | — |
Return on assets | -68.76% | — |
Return on capital | -93.55% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.09M | 81.63% |
Cash from operations | -6.87M | 56.48% |
Cash from investing | 2.49M | -63.77% |
Cash from financing | — | — |
Net change in cash | -4.37M | 50.82% |
Free cash flow | -2.75M | — |
About
Founded
2015
Website
Employees
16
